Free Trial

Korro Bio (KRRO) Stock Price, News & Analysis

Korro Bio logo
$48.77 +5.07 (+11.60%)
Closing price 04:00 PM Eastern
Extended Trading
$47.15 -1.62 (-3.32%)
As of 05:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Korro Bio Stock (NASDAQ:KRRO)

Advanced

Key Stats

Today's Range
$43.70
$49.41
50-Day Range
$13.85
$48.77
52-Week Range
$10.29
$98.00
Volume
229,440 shs
Average Volume
237,015 shs
Market Capitalization
$457.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$86.83
Consensus Rating
Buy

Company Overview

Korro Bio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
44th Percentile Overall Score

KRRO MarketRank™: 

Korro Bio scored higher than 44% of companies evaluated by MarketBeat, and ranked 645th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Korro Bio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 5 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Korro Bio has a consensus price target of $86.83, representing about 78.0% upside from its current price of $48.77.

  • Amount of Analyst Coverage

    Korro Bio has only been the subject of 4 research reports in the past 90 days.

  • Read more about Korro Bio's stock forecast and price target.
  • Earnings Growth

    Earnings for Korro Bio are expected to decrease in the coming year, from ($9.52) to ($10.22) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Korro Bio is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Korro Bio is -5.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Korro Bio has a P/B Ratio of 2.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Korro Bio's valuation and earnings.
  • Percentage of Shares Shorted

    28.08% of the float of Korro Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Korro Bio has a short interest ratio ("days to cover") of 8.7.
  • Change versus previous month

    Short interest in Korro Bio has recently increased by 23.33%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Korro Bio does not currently pay a dividend.

  • Dividend Growth

    Korro Bio does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    28.08% of the float of Korro Bio has been sold short.
  • Short Interest Ratio / Days to Cover

    Korro Bio has a short interest ratio ("days to cover") of 8.7.
  • Change versus previous month

    Short interest in Korro Bio has recently increased by 23.33%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Korro Bio has a news sentiment score of 1.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Korro Bio this week, compared to 3 articles on an average week.
  • Search Interest

    10 people have searched for KRRO on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Korro Bio to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Korro Bio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 4.60% of the stock of Korro Bio is held by insiders.

  • Percentage Held by Institutions

    Only 13.18% of the stock of Korro Bio is held by institutions.

  • Read more about Korro Bio's insider trading history.
Receive KRRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Korro Bio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

KRRO Stock News Headlines

Korro Bio management to meet with Piper Sandler
Shots officially fired…
Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the rights to deliver direct-to-cell service nationwide — a move tech analyst Jeff Brown says could shape the backbone of the coming space economy and create fortunes on a scale not seen since the rise of NVIDIA.tc pixel
See More Headlines

KRRO Stock Analysis - Frequently Asked Questions

Korro Bio's stock was trading at $38.07 at the start of the year. Since then, KRRO shares have increased by 28.1% and is now trading at $48.77.

Korro Bio, Inc. (NASDAQ:KRRO) issued its quarterly earnings results on Tuesday, August, 12th. The company reported ($2.74) EPS for the quarter, missing analysts' consensus estimates of ($2.54) by $0.20. The company had revenue of $1.46 million for the quarter, compared to analyst estimates of $0.41 million.

Shares of KRRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Korro Bio investors own include Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), JPMorgan Chase & Co. (JPM), Netflix (NFLX) and Home Depot (HD).

Company Calendar

Last Earnings
8/12/2025
Today
10/07/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KRRO
Previous Symbol
NASDAQ:KRRO
CIK
1703647
Fax
N/A
Employees
70
Year Founded
2018

Price Target and Rating

High Price Target
$147.00
Low Price Target
$25.00
Potential Upside/Downside
+88.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
8 Analysts

Profitability

EPS (Trailing Twelve Months)
($9.75)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$83.58 million
Net Margins
N/A
Pretax Margin
-1,452.95%
Return on Equity
-61.51%
Return on Assets
-42.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.98
Quick Ratio
5.98

Sales & Book Value

Annual Sales
$6.28 million
Price / Sales
69.03
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$17.12 per share
Price / Book
2.70

Miscellaneous

Outstanding Shares
9,391,000
Free Float
8,959,000
Market Cap
$433.57 million
Optionable
No Data
Beta
2.89

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:KRRO) was last updated on 10/7/2025 by MarketBeat.com Staff
From Our Partners